New study shows stage III colon cancer recurrence can be prevented if eating 2 ounces of tree nuts per week

According to the latest research, yet to be presented during the American Society of Clinical Oncology Annual Meeting this year in Chicago, survival rate of patients suffering from stage 3 colon cancer can be significantly improved with the regular consumption of tree nuts, such as: cashew nuts, hazelnuts, walnuts, almonds and pecans. Moreover, these kind of fruits can also benefit metabolism and cardiovascular health.

Lead author of the study, Dr. Temidayo Fadelu, from Dana Farber Cancer Institute in Boston recommends his patients to include all kinds of tree nuts into their daily diet in order to enjoy the lower cancer risk benefits.

The conclusions of the research came after 826 patients were assessed by using a dietary questionnaire. According to study results, the ones that ate at least 2 ounces of nuts on a weekly basis had a 42 per cent lower cancer recurrence risk when compared to other groups like, for example, the ones regularly consuming peanut butter.

Based on the results of the research, Dr. Fadelu and his team aim to further extend their findings, as explained:

“Ultimately, we need to understand how nuts confer this protective effect, as well as possibly conduct a randomized, controlled clinical trial where diet recommendations are given at the start of the study to prove that tree nuts can reduce recurrence and death after treatment for colon cancer.”

Nevertheless, as the American Society of Clinical Oncology suggests, eating a healthy diet should not replace standard chemotherapy and other treatments leading to dramatic improvements in 5-year survival rates and the quality of life during the disease.